Ab Initio Proud to Sponsor RACI Pharmaceutical Science Seminar Series

Ab Initio was a proud sponsor of the Royal Australian Chemical Institute's Pharmaceutical Science Group clinical trials seminar in Sydney this week. A Great event with some interesting take home messages for SMEs and start-ups developing new therapeutics that are trial ready.

The event was Chaired by Dr Duncan Macinnis, Director of Stakeholder Engagement for MTPConnect and had speakers from the Therapeutic Goods Administration (Dr Katherine Clark, Director, Licensing and Compliance Strategy Section). Easton Pty Ltd (J udy Bingham). Syntro Health (Craig Rogers), the Active Pharmaceutical Ingredient Manufacturers’ Association of Australia (Dr Jurgen Lindner) the RACI (David Edmonds) and Ab Initio Pharma (CEO, Paul Young).

The Seminar series focused on being trial ready and two key themes came across from all speakers and questions from the audience. (1) Plan for the finish line of product registration by building a framework that ensures quality data collection from day one, and (2) no matter what stage of the development cycle you are at, work to GMP.

The Event was kindly hosted by the Faculty of Pharmacy at University of Sydney and Ab Initio sponsored the event with catering and social events at the end of the day.